Ken Mills

Lead of the Blood Cancer Research Group in the Centre for Cancer Research and Cell Biology (CCRCB) in Queen's University Belfast.
Associate Director for Undergraduate Education
Published over 145 peer-reviewed papers and book chapters.
Research interests include the molecular consequences of epigenetic therapies in myeloid malignancies and identifying drugs for repurposing as therapies for blood cancers